bpc 157 target BPC-157 for athletes and injury treatment: Science, safety, and legal concerns BPC-157 | True Peptides

(2014) Molecular Medicine , 20(1): 658666 Phase 2 clinical study confirming ARA-290 (4 mg daily 28 days) improved HbA1c, lipid profiles, and neuropathic symptoms in type 2 diabetes patients over 56 days

It is likely that the larger number of statistically significant changes to the microbiome observed in the groups switched from WD to LD reflects their more numerous exposures to different diets, longitudinal changes in dietary exposure, the stress associated with diet switch, the negative energy state achieved by treatment and/or diet-driven weight loss, or a combination of these factors, but it may also be related to differences in terminal body weight and fat mass since both adiposity and diet composition have been shown to modulate the mouse gut microbiome profile

The appropriate peptide concentration, at the recommended dose, brings the expected supportive effect

TB500 is a synthetic heptapeptide (7 amino acids) derived from the actin-binding region of thymosin beta-4

doi: 10.2147/jir.s383441